Esperion Therapeutics Inc (ESPR) Gross Profit Margin starting from the first quarter 2026 to first quarter 2025, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket
 


Esperion Therapeutics Inc   (NASDAQ: ESPR)


Esperion Therapeutics Inc 's Gross Profit Margin by quarter

Trends, Rankings, Statistics



ESPR Gross Profit Margin (Mar 31 2026)
Q1
(Dec 31 2025)
Q4
(Sep 30 2025)
Q3
(Jun 30 2025)
Q2
(Mar 31 2025)
Q1
Y / Y Revenue Change 23.25 %
Seq. Revenue Change -52.45 %
Revenue In Millions $80.10
Gross Profit Margin 0 %
Gross Profit Margin Total Ranking # 610
Gross Profit In Millions $0.00
Y / Y Gross Profit Change -
Seq. Gross Profit Change -


Commenting First Quarter 2026 Gross Profit Margin



Observing first quarter 2026 results within Major Pharmaceutical Preparations industry 87 other companies have achieved higher Gross Profit Margin. While overall Gross Profit Margin ranking remained unchanged compared to the previous quarter at no. .
Learn about Gross Margin
ESPR's Gross Profit Margin first quarter 2026 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 88
Healthcare Sector # 156
Overall # 610

Gross Profit Margin Statistics
High Average Low
100 % 100 % 100 %
(Mar 31 2026)  




Other Gross Profit Margin Profitability Ratios
ESPR's Cumulative Gross Profit Margin
Major Pharmaceutical Preparations Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
ESPR's Gross Profit Margin Profitability versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for ESPR's Competitors
Gross Profit Margin Profit Margin for Esperion Therapeutics Inc 's Suppliers
Gross Profit Margin Profit Margin for ESPR's Customers

You may also want to know
ESPR's Annual Growth Rates ESPR's Profitability Ratios ESPR's Asset Turnover Ratio ESPR's Dividend Growth
ESPR's Roe ESPR's Valuation Ratios ESPR's Financial Strength Ratios ESPR's Gross Profit Growth
ESPR's Roa ESPR's Inventory Turnover Ratio ESPR's Growth Rates ESPR's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Mar 31 2026, within Major Pharmaceutical Preparations Industry Gross Profit MarginMar 31 2026 MRQ Gross ProfitMar 31 2026 MRQ Revenue




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.